The Use of Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Rituximab (Primary)
- Indications Membranous glomerulonephritis
- Focus Adverse reactions; Pharmacokinetics
- 24 Oct 2014 New trial record